NEW YORK (GenomeWeb) –N-of-One has agreed to provide Inivata with analysis support for its InVision liquid biopsy product line.

Under the terms of the agreement, N-of-One will provide oncologists with individualized reports for patients tested with Inivata's ctDNA-based 34 gene panel. The InVision panel uses a tagged-amplicon sequencing method prior to sequencing, which enables amplification and deep sequencing of genomic regions spanning thousands of bases from individual copies of fragmented DNA.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.